Off balance sheet commitments (Details) $ in Millions |
1 Months Ended |
|---|---|
|
Mar. 31, 2026
USD ($)
| |
| CTTQ | CTTQ Rovidicitinib license agreement | |
| Disclosure Of Off Balance Sheet Commitments [Line Items] | |
| Upfront license payment | $ 135 |
| Collaboration agreement development, regulatory and sales milestone payments | 1,400 |
| Kali Therapeutics | Kali Therapeutics License Agreement | |
| Disclosure Of Off Balance Sheet Commitments [Line Items] | |
| Upfront license payment | 100 |
| Collaboration agreement development, regulatory and sales milestone payments | $ 1,200 |